(KVT) Krynica Vitamin - Ratings and Ratios
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLKRVTM00010
KVT EPS (Earnings per Share)
KVT Revenue
KVT: Energy, Functional, Soft, Coffee, Dairy
Krynica Vitamin S.A. is a Polish beverage company with a diverse product portfolio that includes energy drinks, functional beverages, carbonated soft drinks, alcopops, coffee, and dairy drinks, catering to a broad customer base across Europe and beyond. The companys product offerings are packaged in various formats, including aluminum cans, PET bottles, and glass bottles, allowing it to adapt to different market preferences and distribution channels. In addition to its own branded products, Krynica Vitamin S.A. provides contract manufacturing services for other brands, leveraging its production capabilities to generate additional revenue streams.
With its headquarters in Warsaw, Poland, Krynica Vitamin S.A. operates as a subsidiary of Zinat Sp. Z O.O., indicating a level of corporate oversight and strategic guidance. The companys website (https://www.krynicavitamin.com) serves as a platform for communicating with stakeholders, showcasing its products, and potentially providing investor information.
Analyzing the companys stock performance, we observe that Krynica Vitamin S.A.s shares are currently trading at 9.68 PLN, slightly below its 20-day simple moving average (SMA20) of 10.02 PLN, indicating a potential short-term bearish trend. However, the stocks 50-day SMA stands at 9.39 PLN, suggesting a longer-term bullish outlook. The average true range (ATR) of 0.50 PLN, equivalent to 5.12% of the current price, implies moderate volatility. Considering the stocks 52-week high and low of 12.40 PLN and 8.00 PLN, respectively, we can infer that the current price is relatively closer to the lower end of its recent trading range.
From a fundamental perspective, Krynica Vitamin S.A.s market capitalization stands at 121.05M PLN, with a price-to-earnings (P/E) ratio of 9.88, indicating a relatively reasonable valuation. The companys return on equity (RoE) of 13.79% suggests a satisfactory level of profitability. By combining these fundamental insights with the technical analysis, we can forecast that Krynica Vitamin S.A.s stock may experience a moderate upward trend in the short to medium term, driven by its relatively attractive valuation and decent profitability. A potential price target could be around 11.00 PLN, representing a 13.6% increase from the current level, contingent upon the companys ability to maintain its profitability and navigate the competitive beverage market effectively.
Additional Sources for KVT Stock
KVT Stock Overview
Market Cap in USD | 32m |
Sector | Consumer Defensive |
Industry | Beverages - Non-Alcoholic |
GiC Sub-Industry | Soft Drinks & Non-alcoholic Beverages |
IPO / Inception |
KVT Stock Ratings
Growth Rating | -3.76 |
Fundamental | 43.1 |
Dividend Rating | 1.0 |
Rel. Strength | -26.5 |
Analysts | - |
Fair Price Momentum | 8.18 PLN |
Fair Price DCF | 35.36 PLN |
KVT Dividends
Currently no dividends paidKVT Growth Ratios
Growth Correlation 3m | 77.9% |
Growth Correlation 12m | -76.1% |
Growth Correlation 5y | -55.7% |
CAGR 5y | 19.34% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | -0.12 |
Alpha | -29.98 |
Beta | 0.364 |
Volatility | 32.74% |
Current Volume | 0.3k |
Average Volume 20d | 1.1k |
As of June 01, 2025, the stock is trading at PLN 9.50 with a total of 341 shares traded.
Over the past week, the price has changed by -3.06%, over one month by -10.80%, over three months by +5.79% and over the past year by -17.03%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Krynica Vitamin (WAR:KVT) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 43.12 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of KVT is around 8.18 PLN . This means that KVT is currently overvalued and has a potential downside of -13.89%.
Krynica Vitamin has no consensus analysts rating.
According to our own proprietary Forecast Model, KVT Krynica Vitamin will be worth about 8.9 in June 2026. The stock is currently trading at 9.50. This means that the stock has a potential downside of -6.11%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 8.9 | -6.1% |